Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.AI Announces Increase in Revenue Growth for Arway with Map D Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vistagen Therapeutics Inc VTGN

Healthcare Biotechnology
Vistagen Therapeutics, Inc. is a neuroscience-focused biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for psychiatric and neurological disorders based on its understanding of nose-to-brain neurocircuitry. Its clinical-stage pipeline consists of intranasal product candidates from a new class of potential neuroscience therapies called... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VTGN)

Vistagen to Present at the 2025 Anxiety and Depression Association Conference

Business Wire 22 hours ago

Vistagen to Participate in Stifel 2025 Virtual CNS Forum

Business Wire March 4, 2025

Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference

Business Wire February 20, 2025

Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update

Business Wire February 13, 2025

Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025

Business Wire February 6, 2025

Vistagen Receives U.S. Patent for AV-101 to Treat Neuropathic Pain

Business Wire February 5, 2025

Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia

Business Wire January 14, 2025

Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder

Business Wire January 10, 2025

Vistagen to Present at the Stifel 2024 Healthcare Conference

Business Wire November 14, 2024
View More News ››

Opinion & Analysis (NDAQ:VTGN)

VistaGen's fast-acting antidepressant targets multibillion-dollar market

The Life Sciences Report April 27, 2017

VistaGen Therapeutics advances new-generation antidepressant approved by European Patent Office

The Life Sciences Report April 6, 2017

VistaGen licenses stem cell technology to new firm backed by big pharma

The Life Sciences Report December 23, 2016

How markets are rigged against you

Stockhouse Editorial April 14, 2014
View More Opinion ››

Bullboard Posts (NDAQ:VTGN)

Vasta Platform Limited to Report Fourth Quarter and Full Yea

NEWS: $VSTA Vasta Platform Limited to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025Vasta Platform Limited...
whytestocks - February 24, 2025

Vistagen Broadens PH80 Global Intellectual Property Portfoli

Breaking News: $VTGN Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of...
whytestocks - July 9, 2024

Vistagen Awarded Mental Health America's Platinum Bell Seal

BREAKING NEWS: $VTGN Vistagen Awarded Mental Health America's Platinum Bell Seal for Workplace Mental Health for the Second...
whytestocks - June 27, 2024

VistaGen Therapeutics (NASDAQ : VTGN) Analysis

https://10xalerts.com/vistagen-therapeutics-nasdaq-vtgn-analysis/
Brice978 - April 30, 2024

VSTA - Friday Rundown, Monday Expectations

<< View Post To Watch Video >>
HDavis - December 10, 2021

RE:RE:VTGN - Flying with out any news

Yes a lot of volatility right now. Can be good to avoid this stock for now. Depression stocks will soon be out of favour, when the Covid...
canarsta - January 26, 2021
View more Bullboard ››

Silvercorp Metals Inc.

Silvercorp Metals Inc.

Silvercorp is a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability and ...
View More »